International Medical Journal (ISSN:13412051)

Aim and Scope

Aim-

International Medical Journal ISSN: (13412051) is an international open-access journal publishes twelve times each year. The "International Medical Journal" is a peer-reviewed, monthly, online international research journal, which publishes original articles, research articles, review articles with top-level work from all areas of Medical Science Research and their application including Aetiology, bioengineering, biomedicine, cardiology, chiropody, ENT etc. Researchers in all Medical Science and Pharmacy fields are encouraged to contribute articles based on recent research. Journal publishes research articles and reviews within the whole field of Medical Science and Pharmacy Research, and it will continue to provide information on the latest trends and developments in this ever-expanding subject. International Medical Journal journal covers almost all disciplines of Medical Science and Pharmacy. Researchers and students of M.B.B.S, M.D., D.T.C.D., GYNE., M.S., M.Pharma, And PhD are requested to send their original research articles to International Medical Journal. Azerbaijan Medical Journal Gongcheng Kexue Yu Jishu/Advanced Engineering Science Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery

Scope-

International Medical Journal ISSN: (13412051) is a peer-reviewed journal. The journal seeks to publish original research articles that are hypothetical and theoretical in its nature and that provide exploratory insights in the following fields but not limited to:

Anatomy Physiology Biochemistry Pharmacology
Pathology Forensic medicine Microbiology Community Medicine
Otorhinolaryngology Internal Medicine General Surgery Obstetrics and Gynecology
Radiology Pulmonary Medicine Dermatology and Venereal diseases Infectious Diseases
Anaesthesia Cancer research Neurosurgery Orthopedics

See More Scopes

Latest Journals
International Medical Journal
Journal ID : IMJ-05-09-2021-920
Total View : 394

Abstract : The objective of the present study is to evaluate the invitro attenuation of coagulation by Dracaena sanderiana. Prothrombin time assesses coagulation factors in extrinsic pathway (factors VII) and common pathway (factors X, V prothrombin and fibrinogen), thus with the help of UNIPLASTIN reagent a protocol has been prepared to evaluate the anticoagulant activity of Dracaena sanderiana. It was observed that Dracaena sanderiana at different concentrations significantly prolonged the clotting time in a concentration dependent manner against the standard EDTA. Thus, it can be concluded that the ethanolic extract of Dracaena sanderiana possesses pharmacologically active anticoagulant component which might be helpful to for blood coagulation disorders..
Full article
International Medical Journal
Journal ID : IMJ-04-09-2021-919
Total View : 359

Abstract : Tuberculosis is an infection induced by the Mycobacterium tuberculosis bacteria. Tuberculosis usually targets the lungs, but can also involve all other organs. Incidence of laryngeal tuberculosis is low. Patients who are AFB +ve have sputum contaminated with the M. tuberculosis bacteria which gets lodged in various subsites of the larynx in susceptible patients leading to laryngeal tuberculosis. This study was conducted in a tertiary pulmonary care centre on 130 AFB +ve patients who were referred to the ENT dept with complaints of dysphonia, odynophagia, and prolonged hoarseness of voice. All the patients were already receiving ATT. Eleven patients who had varied lesions of the larynx were subjected to endoscopy and biopsy; histological examination of the biopsy specimens revealed tuberculous granuloma with presence of giant cells confirming laryngeal tuberculosis. India has the highest number of tuberculosis patients in the world and it is advisable to subject all patients of pulmonary tuberculosis who have long standing laryngeal symptoms to a proper ENT examination including direct laryngoscopy to rule out or establish laryngeal tuberculosis..
Full article
International Medical Journal
Journal ID : IMJ-04-09-2021-918
Total View : 402

Abstract : Teratozoospermia is characterized by the presence of spermatozoa with abnormal morphology in sperm. Globozoospermia is a rare (incidence 0.1%) and severe form of teratozoospermia characterized by the presence in the ejaculate of a large majority of round spermatozoa without acrosome. Globozoospermia is most commonly caused by mutations in the DPY19L2 gene. Globozoospermic spermatozoa are thus unable to adhere and to penetrate the zona pellucida, causing primary infertility. The results: total teratospermia 100% (globospermia 89% and other forms of abnormal morphology 11%), necrosospermia 69%, astenozospemia 99%. The case presented is the first to be published as a pathology of infertility in the Republic of Kosovo. Teratozospermia in the form of Globozoospermia was 89%, and we called it Globospermia severe or Globospermia type III, based on the results of 100% atypical morphology (89% globospermia + 11% other atypical forms) and Necrosospermia 69% as well as Asthenzospermia 99 %..
Full article
International Medical Journal
Journal ID : IMJ-03-09-2021-917
Total View : 437

Abstract :

Patients with NSCLC EGFR mutations are patients with advanced stage (stage IIIb/IV) who use targeted therapy as the main therapy such as the Tyrosine Kinase Inhibitors/TKIs (afatinib, gefitinib and erlotinib), the number of treatments received by the patient and the worsening disease prognosis can impact on the economic burden of patients and the Government. This study aims to determine the economic impact of Non-Small Cell Lung Cancer with EGFR mutations in Indonesia. This research is a retrospective observational study with a cross sectional research design that uses the perspective of health provider (health care facilities) and societal (community) conducted at Dr Sardjito Hospital Yogyakarta and Dr Kariadi Hospital Semarang, Indonesia. The results showed that the unit cost of therapy in Non-Small Cell Lung Cancer patients with EGFR mutations using afatinib therapy was Rp. 120,881,289, - and in gefitinib that is Rp. 90.750.186,-. With an average direct medical cost of Rp. 189,699, - and an indirect cost of Rp. 2.250,700.

.
Full article
International Medical Journal
Journal ID : IMJ-03-09-2021-916
Total View : 364

Abstract : Diabetes Mellitus is a chronic disease that requires a long treatment therapy so that it requires a large amount of money. This study aims to determine the use of antidiabetics and the total cost of therapy for type 2 DM patients in Riau Province, Indonesia.This type of research is observational, descriptive. To determine direct medical costs, data were taken retrospectively from the medical records of outpatient type 2 diabetes mellitus patients at Arifin Achmad Hospital between October 2016 and March 2017.Data were also taken concurrently, namely by conducting interviews to determine direct non- medical costs in patients with type 2 diabetes mellitus. The results obtained were the average total cost per month was Rp. 375,974.54. Direct medical costs include antidiabetic costs of Rp 46,430.53, complication costs of Rp 47,246.90, doctor's examination fees of Rp 25,000, laboratory examination fees of Rp 61,183.84, and diet costs of Rp 46,798.22. Direct non-medical costs include transportation costs of Rp. 24,845.36, while indirect costs are Rp. 122,954.54..
Full article

Our Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
//